Diagnostics

Medical Diagnostics Market Research Reports

Medical Diagnostics Market Research Reports, Analysis & Trends

 
Publication Single User License (PDF) Price
Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics

Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics

Date Published: Dec 1 2014

The Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty asset purchase deals.

$2,995.00
Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Date Published: Dec 1 2014

The Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the world’s biopharma companies

$3,295.00
Gene Therapy Partnering Terms and Agreements

Gene Therapy Partnering Terms and Agreements

Date Published: Dec 1 2014

The Gene Therapy Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.

$1,995.00
Cancer Vaccine Partnering Terms and Agreements

Cancer Vaccine Partnering Terms and Agreements

Date Published: Dec 1 2014

The Cancer Vaccine Partnering Agreements Terms and Agreements report provides comprehensive understanding and unprecedented access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.

$1,995.00
Cancer Diagnostics Partnering Terms and Agreements

Cancer Diagnostics Partnering Terms and Agreements

Date Published: Dec 1 2014

The Cancer Diagnostics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.

$2,995.00
Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Date Published: Dec 1 2014

The Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the royalty financing partnering agreements entered into by the worlds leading healthcare companies.

Description
The Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals.

$1,995.00
Interventional Cardiology (Devices & Technology) - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

Interventional Cardiology (Devices & Technology) - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

Date Published: Nov 3 2014
BRICSS Interventional Cardiology Devices sector is projected to reach at US$3.3 billion by 2016. China accounts for highest percentage approximately 28% (2015) of global share while India follows next with nearly 25% (2018) of the market. Forecasts for Cardiac Catheters indicate a close 50%, while Arteriotomy Closure Devices accounts for nearly 6% of the market share.
$3,100.00
Hemodynamic Monitoring Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

Hemodynamic Monitoring Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

Date Published: Nov 3 2014
BRICSS Hemodynamic Monitoring Devices market value is expected to reach US$281 million by 2016, primarily supported by the product types - Cardiac Output Monitoring Devices and Pulmonary Artery Catheters. China accounts for nearly 24% of the market share and India claims more than 24%. In terms of CAGR, India is the fastest growing region while China and South Korea are just behind.
$2,500.00
Acne Partnering 2009-2014

Acne Partnering 2009-2014

Date Published: Nov 1 2014

Provides understanding and access to the acne partnering deals and agreements entered into by the worlds leading healthcare companies

Description
Acne Partnering 2009-2014 report provides understanding and access to the acne partnering deals and agreements entered into by the worlds leading healthcare companies.

•Trends in acne partnering deals
•Top acne deals by value
•Deals listed by company A-Z, industry sector, stage of development, technology type

$695.00
Actavis Partnering 2009-2014

Actavis Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Actavis and its partnering interests and activities over the past seven years

Description
This report provides all the information you require to better understand Actavis and its partnering interests and activities over the past seven years.

$995.00
Shire Partnering 2009-2014

Shire Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Shire and its partnering interests and activities over the past seven years.

Description
The Partnering Agreements with Shire report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.

This report provides all the information you require to better understand Shire and its partnering interests and activities over the past five years.

$995.00
Inflammatory Partnering 2009-2014

Inflammatory Partnering 2009-2014

Date Published: Nov 1 2014

Inflammatory Partnering 2009-2014 report provides understanding and access to the inflammatory partnering deals and agreements entered into by the worlds leading healthcare companies

Description
Inflammatory Partnering 2009-2014 report provides understanding and access to the inflammatory partnering deals and agreements entered into by the worlds leading healthcare companies.

•Trends in inflammatory partnering deals
•Top inflammatory deals by value
•Deals listed by company A-Z, industry sector, stage of development, technology type

$995.00
Covidien Partnering 2009-2014

Covidien Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Covidien and its partnering interests and activities over the past seven years.

Description
The Partnering Agreements with Covidien 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.

This report provides all the information you require to better understand Covidien and its partnering interests and activities over the past seven years.

$995.00
Lymphoma Partnering 2009-2014

Lymphoma Partnering 2009-2014

Date Published: Nov 1 2014

The Lymphoma Partnering 2009-2014 report provides understanding and access to the lymphoma partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in lymphoma partnering deals
Top lymphoma deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

Description
The Lymphoma Partnering 2009-2014 provides understanding and access to the lymphoma partnering deals and agreements entered into by the worlds leading healthcare companies.

$995.00
Osteoporosis Partnering 2009-2014

Osteoporosis Partnering 2009-2014

Date Published: Nov 1 2014

The Osteoporosis Partnering 2009-2014 report provides understanding and access to the osteoporosis partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Osteoporosis Partnering 2009-2014 report provides understanding and access to the osteoporosis partnering deals and agreements entered into by the worlds leading healthcare companies.

•Trends in osteoporosis partnering deals
•Top osteoporosis deals by value
•Deals listed by company A-Z, industry sector, stage of development, technology type

$695.00
Kyowa Hakko Partnering 2009-2014

Kyowa Hakko Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Kyowa Hakko Kirin and its partnering interests and activities over the past seven years.

Description
The Partnering Agreements with Kyowa Hakko Kirin report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.

This report provides all the information you require to better understand Kyowa Hakko Kirin and its partnering interests and activities over the past five years.

$995.00
Nektar Therapeutics Partnering 2009-2014

Nektar Therapeutics Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Nektar Therapeutics and its partnering interests and activities over the past seven years

Description
The Partnering Agreements with Nektar Therapeutics 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.

This report provides all the information you require to better understand Nektar Therapeutics and its partnering interests and activities over the past seven years.

$995.00
Ulcerative Colitis Partnering 2009-2014

Ulcerative Colitis Partnering 2009-2014

Date Published: Nov 1 2014

The Ulcerative Colitis Partnering 2009-2014 report provides understanding and access to the ulcerative colitis partnering deals and agreements entered into by the worlds leading healthcare companies

Description
The Ulcerative Colitis Partnering 2009-2014 report provides understanding and access to the ulcerative colitis partnering deals and agreements entered into by the worlds leading healthcare companies.

$695.00
Apotex Partnering 2009-2014

Apotex Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Apotex and its partnering interests and activities over the past seven years

Description
This report provides all the information you require to better understand Apotex and its partnering interests and activities over the past seven years.

$995.00
UCB Partnering 2009-2014

UCB Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand UCB and its partnering interests and activities over the past seven years.

Description
The Partnering Agreements with UCB report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.

This report provides all the information you require to better understand UCB and its partnering interests and activities over the past five years.

$995.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data